According to Nektar Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ41.44 Million. a decrease over the revenue in the year 2024 that were of ยฃ78.43 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.